Diabetic Retinopathy

Diabetic retinopathy is a complication of diabetes, caused by persistent high blood sugar levels, which can damage the blood vessels needed to supply blood to the retina, causing oedema or/and ischaemia. Despite strong evidence documenting the effectiveness of routine screening to prevent loss of vision due to diabetic retinopathy, the condition is becoming more prevalent and a growing concern amongst ophthalmologists. Currently there is no available treatment for ischaemic diabetic retinopathy, whereas macular oedema can be treated with intravitreal injections, which were proven to be much more effective when in conjunction with Omega 3.

Eylea injections combined with Omega 3 provide better visual outcome in diabetic retinopathy (DR)

Patients with diabetic retinopathy not responding to Avastin injections were treated with Eylea injections with or without Omega 3.

Georgiou, et al. 2019

Supportive Research

3482 participants with type 2 diabetes, taking at least 2 weekly servings of oily fish at baseline showed a 48% relatively reduced risk of incident sight-threatening diabetic retinopathy compared with those not meeting this target.

Sala-Vila, 2016

A mouse model of oxygen-induced retinopathy has shown that increasing Omega 3 tissue levels reduces pathological angiogenesis .These results indicate that enriching the sources of Omega 3 may be an effective therapeutic approach to help prevent proliferative retinopathy.

Connor et al, 2007

Omega-3 fatty acids have great potential to prevent the progression of diabetic retinopathy, due to their wide range of protective properties, such as anti-inflammatory, antiangiogenic, and antioxidant.

Behl & Kotwani, 2017

Diabetic Retinopathy